J. Luna
Impact in
- Ophthalmology top 10%
- Retinal Diseases and Treatments
-
- Cell Adhesion Molecules Research
Papers in
-
- Lung Cancer Treatments and Mutations 6
- Lung Cancer Diagnosis and Treatment 6
- Oncology 9
- Lung Cancer Research Studies 4
- Cancer Immunotherapy and Biomarkers 3
- COVID-19 and healthcare impacts 2
- Inflammatory Biomarkers in Disease Prognosis 1
- Co-authors
- Takao Tobe (1 shared paper)Peter A. Campochiaro (1 shared paper)Shaker A. Mousa (1 shared paper)Thomas M. Reilly (1 shared paper)I. Prieto (6 shared papers)Felipe Couñago (11 shared papers)Enrique Amaya (2 shared papers)Aurora Rodríguez Pérez (5 shared papers)
- Journals
- World Journal of Clinical Oncology (5 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)Cancers (2 papers)Future Oncology (1 paper)Clinical Lung Cancer (1 paper)
- Partner nations
- SpainUnited States
In The Last Decade
J. Luna
18 papers receiving 307 citations
Peers
Comparison fields: 5 of 55
- Ophthalmology 49
- Immunology and Allergy 32
- Oncology 78
- Pulmonary and Respiratory Medicine 86
- Cancer Research 35
Countries citing papers authored by J. Luna
This map shows the geographic impact of J. Luna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Luna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Luna more than expected).
Fields of papers citing papers by J. Luna
This network shows the impact of papers produced by J. Luna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Luna. The network helps show where J. Luna may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Luna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine model. | 1996 | 98 |
| 2 | 2016 | 64 | |
| 3 | 2019 | 37 | |
| 4 | 2021 | 17 | |
| 5 | 2020 | 17 | |
| 6 | 2021 | 16 | |
| 7 | 2016 | 14 | |
| 8 | 2018 | 12 | |
| 9 | 2021 | 9 | |
| 10 | 2020 | 9 | |
| 11 | 2021 | 5 | |
| 12 | 2022 | 5 | |
| 13 | 2015 | 3 | |
| 14 | 2021 | 2 | |
| 15 | 2012 | 1 | |
| 16 | 2023 | 1 | |
| 17 | 2015 | 1 | |
| 18 | 2014 | 1 | |
| 19 | 2011 | 0 |
About J. Luna
J. Luna is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Infectious Diseases and Molecular Biology, having authored 19 papers that have together received 312 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (6 papers), Lung Cancer Research Studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), COVID-19 and healthcare impacts (2 papers), Endometrial and Cervical Cancer Treatments (1 paper), Inflammatory Biomarkers in Disease Prognosis (1 paper) and Head and Neck Cancer Studies (1 paper). The work is most often cited by research in Ophthalmology (49 citations), Immunology and Allergy (32 citations), Oncology (78 citations), Pulmonary and Respiratory Medicine (86 citations) and Cancer Research (35 citations). J. Luna has collaborated with scholars based in Spain and United States. Frequent co-authors include Takao Tobe, Peter A. Campochiaro, Shaker A. Mousa, Thomas M. Reilly, I. Prieto, Felipe Couñago, Enrique Amaya, Aurora Rodríguez Pérez, Xabier Mielgo-Rubio and M. Martín. Their work appears in journals such as World Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Cancers, Future Oncology and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.